Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
25.49
+0.93 (3.79%)
At close: Aug 19, 2026, 4:00 PM EDT
25.99
+0.50 (1.96%)
After-hours: Aug 19, 2026, 7:43 PM EDT

Adaptive Biotechnologies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-63.85-59.5-159.49-225.25-200.19-207.28
Depreciation & Amortization
16.1317.8319.2622.2320.9213.95
Asset Writedown & Restructuring Costs
0.35-7.2125.43--
Loss (Gain) From Sale of Investments
-1.05-2.51-8.21-9.180.747.23
Stock-Based Compensation
49.0251.4853.6162.9155.4843.25
Other Operating Activities
20.794.489.8713.7310.656.93
Change in Accounts Receivable
-5.23-8.65-3.742.03-22.65-7.36
Change in Inventory
-2.11-15.37-2.840.82-5.2
Change in Accounts Payable
0.560.670.67-5.417.113.94
Change in Unearned Revenue
-21.47-36.75-10.48-29.29-56.5-57.73
Change in Other Net Operating Assets
-14.14-12.04-9.28-10.68-0.339.53
Operating Cash Flow
-21.01-45.99-95.21-156.32-183.95-192.73
Operating Cash Flow Growth
------
Capital Expenditures
-3.03-2.96-3.66-10.7-16.35-61.75
Investment in Securities
-22.2840.9181.46140.3419.25242.96
Investing Cash Flow
-25.337.9577.79129.652.91181.21
Issuance of Common Stock
36.2230.40.242.257.8926.72
Other Financing Activities
-25.6---124.380.43
Financing Cash Flow
173.0330.40.242.25132.2727.15
Net Cash Flow
126.7222.37-17.18-24.43-48.7815.63
Free Cash Flow
-24.03-48.95-98.88-167.02-200.29-254.47
Free Cash Flow Growth
------
Free Cash Flow Margin
-7.80%-17.67%-55.25%-98.09%-108.09%-164.87%
Free Cash Flow Per Share
-0.15-0.32-0.67-1.16-1.41-1.81
Levered Free Cash Flow
18.980.95-24.48-81.95-90.17-139.1
Unlevered Free Cash Flow
26.178.31-17.24-73.33-87.53-139.1
Cash Interest Paid
23.612.648.868.990.49-
Change in Working Capital
-42.39-57.77-17.45-46.18-71.55-56.82
SEC Filings: 10-K · 10-Q